Radiotherapy (RT) is used to treat approximately 80% of patients with cancer of the head
and neck. Despite enormous advances in RT planning and delivery, a significant number of …

Salivary glands sustain collateral damage following radiotherapy (RT) to treat cancers of the
head and neck, leading to complications, including mucositis, xerostomia and …

Oncologic treatments, such as curative radiotherapy and chemoradiation, for head and neck
cancer can cause long-term swallowing impairments (dysphagia) that negatively impact …

Purpose Research investigating swallowing problems (dysphagia) and complications within
the oral cavity in non-head and neck cancer patients is limited. The purpose of this study …

Background: The purpose of this study is to evaluate changes in nutrition impact symptoms
(NIS) and nutritional and functional status that occur throughout radiotherapy in head and …

Simple Summary Head and neck cancer is the seventh-most prevalent cancer worldwide.
Despite advances in treatment, many patients suffer from chemoradiation-induced oral …

Purpose/objective (s) We sought to identify swallowing muscle dose–response thresholds
associated with chronic radiation-associated dysphagia (RAD) after IMRT for oropharyngeal …

Objective Extensive research has documented the negative nutritional impact of head neck
cancer (HNC) treatment, but few studies have addressed the patients' experiences. The …

Salivary gland hypofunction is an adverse side effect associated with radiotherapy for head
and neck cancer patients. This study delineated metabolic changes at acute, intermediate …

The risk of radiation-induced toxicity in patients treated for head and neck (HN) cancer with
radiation therapy (RT) is traditionally estimated by condensing the 3D dose distribution into …